Bunkerhill ECG-EF vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by Prolaio

AI Verdict

Tool A is designed for the early identification of heart failure risk by detecting reduced left ventricular ejection fraction from routine 12-lead ECGs. In contrast, Tool B estimates peak oxygen consumption using data from wearable sensors, serving as an adjunctive aid in cardiovascular research and care. While both leverage AI in cardiology, their distinct focus on different biomarkers and data sources makes them suitable for different clinical applications.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is to rapidly screen a large patient population for early signs of reduced left ventricular ejection fraction using existing 12-lead ECG infrastructure. This tool is ideal for integrating into routine clinical workflows to identify patients at risk for heart failure without requiring specialized or additional testing.

View Bunkerhill ECG-EF →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you need to estimate peak oxygen consumption for a more in-depth, longitudinal assessment of a patient's cardiovascular fitness and functional capacity. This tool is particularly well-suited for scenarios involving continuous monitoring via FDA-cleared wearable sensors, providing valuable insights for cardiovascular research, rehabilitation, or personalized care management.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF prolaio eVO2peak Module
Pricing Contact sales for pricing details. Contact for pricing
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Cloud-based (software-only, processes remote sensor data)
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF prolaio eVO2peak Module
Name Bunkerhill ECG-EF prolaio eVO2peak Module
Company BunkerHill Health Prolaio
Description FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. FDA-cleared software to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care.
Key Functionality Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) Estimates peak oxygen consumption (eVO2peak)
Data Input Routine 12-lead ECG data Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and prolaio eVO2peak Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is designed to detect reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. Prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data, serving as an adjunctive aid in clinical evaluation for cardiovascular research and care.
Bunkerhill ECG-EF analyzes routine 12-lead ECG data. Prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
Bunkerhill ECG-EF integrates seamlessly with Electronic Medical Records (EMR) or ECG Management Systems (EMS) and clinical archives. Prolaio eVO2peak Module is cloud-based and processes remote sensor data, enabling high-density, longitudinal data collection.
Bunkerhill ECG-EF offers a non-invasive, rapid, and accessible cardiac diagnostic tool to aid in the early identification of patients at risk for heart failure. Prolaio eVO2peak Module provides information as an adjunctive aid in clinical evaluation, leveraging real-world patient data and insights for cardiovascular research and care.
AI Tool Finder
AI-powered search. Results may not be comprehensive.